Hwang SR - Search Results

1

Properties of Heparinoids Premixed with Tumor-Derived Extracellular Vesicles.

Manandhar S, Park J, Kothandan VK, Lee J, Alam F, Jee JP, Hwang J, Byun Y, Hwang SR. Manandhar S, et al. Among authors: hwang j, hwang sr. Bioconjug Chem. 2018 Nov 21;29(11):3757-3767. doi: 10.1021/acs.bioconjchem.8b00637. Epub 2018 Nov 5. Bioconjug Chem. 2018. PMID: 30372043

2

Orally active desulfated low molecular weight heparin and deoxycholic acid conjugate, 6ODS-LHbD, suppresses neovascularization and bone destruction in arthritis.

Hwang SR, Seo DH, Al-Hilal TA, Jeon OC, Kang JH, Kim SH, Kim HS, Chang YT, Kang YM, Yang VC, Byun Y. Hwang SR, et al. J Control Release. 2012 Nov 10;163(3):374-84. doi: 10.1016/j.jconrel.2012.09.013. Epub 2012 Oct 4. J Control Release. 2012. PMID: 23041275

3

Cyclic RGDyk-conjugated LMWH-taurocholate derivative as a targeting angiogenesis inhibitor.

Adulnirath A, Chung SW, Park J, Hwang SR, Kim JY, Yang VC, Kim SY, Moon HT, Byun Y. Adulnirath A, et al. Among authors: hwang sr. J Control Release. 2012 Nov 28;164(1):8-16. doi: 10.1016/j.jconrel.2012.10.001. Epub 2012 Oct 10. J Control Release. 2012. PMID: 23063549

4

Enhanced oral absorption of ibandronate via complex formation with bile acid derivative.

Park JW, Hwang SR, Jeon OC, Moon HT, Byun Y. Park JW, et al. Among authors: hwang sr. J Pharm Sci. 2013 Feb;102(2):341-6. doi: 10.1002/jps.23413. Epub 2012 Dec 11. J Pharm Sci. 2013. PMID: 23233267

5

Oral delivery of ionic complex of ceftriaxone with bile acid derivative in non-human primates.

Jeon OC, Hwang SR, Al-Hilal TA, Park JW, Moon HT, Lee S, Park JH, Byun Y. Jeon OC, et al. Among authors: hwang sr. Pharm Res. 2013 Apr;30(4):959-67. doi: 10.1007/s11095-012-0932-0. Epub 2013 Jan 5. Pharm Res. 2013. PMID: 23292220

6

TNF-α gene silencing using polymerized siRNA/thiolated glycol chitosan nanoparticles for rheumatoid arthritis.

Lee SJ, Lee A, Hwang SR, Park JS, Jang J, Huh MS, Jo DG, Yoon SY, Byun Y, Kim SH, Kwon IC, Youn I, Kim K. Lee SJ, et al. Among authors: hwang sr. Mol Ther. 2014 Feb;22(2):397-408. doi: 10.1038/mt.2013.245. Epub 2013 Oct 22. Mol Ther. 2014. PMID: 24145554 Free PMC article.

7

Preliminary safety evaluation of a taurocholate-conjugated low-molecular-weight heparin derivative (LHT7): a potent angiogenesis inhibitor.

Alam F, Chung SW, Hwang SR, Kim JY, Park J, Moon HT, Byun Y. Alam F, et al. Among authors: hwang sr. J Appl Toxicol. 2015 Jan;35(1):104-15. doi: 10.1002/jat.2995. Epub 2014 Feb 16. J Appl Toxicol. 2015. PMID: 24532548

8

Advances in oral macromolecular drug delivery.

Hwang SR, Byun Y. Hwang SR, et al. Expert Opin Drug Deliv. 2014 Dec;11(12):1955-67. doi: 10.1517/17425247.2014.945420. Epub 2014 Jul 31. Expert Opin Drug Deliv. 2014. PMID: 25078141 Review.

9

Preclinical safety evaluation of low molecular weight heparin-deoxycholate conjugates as an oral anticoagulant.

Kim JY, Jeon OC, Moon HT, Hwang SR, Byun Y. Kim JY, et al. Among authors: hwang sr. J Appl Toxicol. 2016 Jan;36(1):76-93. doi: 10.1002/jat.3146. Epub 2015 Apr 20. J Appl Toxicol. 2016. PMID: 25900269

10

Chemical Conjugate of Low Molecular Weight Heparin and Suramin Fragment Inhibits Tumor Growth Possibly by Blocking VEGF165.

Park J, Kim JY, Hwang SR, Mahmud F, Byun Y. Park J, et al. Among authors: hwang sr. Mol Pharm. 2015 Nov 2;12(11):3935-42. doi: 10.1021/acs.molpharmaceut.5b00348. Epub 2015 Oct 13. Mol Pharm. 2015. PMID: 26448404

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

114 results

Search Page